Zomedica Pharma earnings missed by $0.01, revenue fell short of estimates

  • Investing.com
Zomedica Pharma earnings missed by $0.01, revenue fell short of estimates
Credit: © Reuters.

Investing.com - Zomedica Pharma (NYSE: ZOM ) reported second quarter EPS of $-0.0100, $0.01 worse than the analyst estimate of $0.0000. Revenue for the quarter came in at $6.02M versus the consensus estimate of $7.34M.

Zomedica Pharma's stock price closed at $0.2000. It is down 0.0000% in the last 3 months and down -42.2800% in the last 12 months.

Zomedica Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Zomedica Pharma's stock price’s past reactions to earnings here.

According to InvestingPro, Zomedica Pharma's Financial Health score is "good performance".

Check out Zomedica Pharma's recent earnings performance , and Zomedica Pharma's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles